[시장보고서]자동 핵산 추출 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 기술별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

자동 핵산 추출 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 기술별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Automated Nucleic Acid Extraction Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Consumables), By Technology (Magnetic Bead-based, Column-based), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033

상품코드 : 1888571

리서치사 : Grand View Research

발행일 : 2025년 11월

페이지 정보 : 영문 120 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,620,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,069,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 12,967,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

자동 핵산 추출 시장 : 개요

세계의 자동 핵산 추출 시장 규모는 2024년에 32억 2,000만 달러로 평가되었으며, 2033년까지 87억 7,000만 달러에 달할 것으로 예측됩니다.

2025년부터 2033년까지 11.89%의 CAGR을 기록할 것으로 예상됩니다. 추출 기술의 지속적인 발전과 더불어 정밀의료, 감염성 질환 검사, 생명공학 연구에서의 유전체학의 응용 확대는 시장의 성장을 더욱 촉진하고 있습니다.

새로운 시료 유형과 과제 기술에 대응하는 기술 혁신

기술 개발로 미량 시료, 임상 검체, FFPE 조직, 순환 세포 유리 핵산 등 복잡한 시료 유형의 처리가 용이해지면서 자동 핵산 추출 시스템의 도입이 빠르게 진행되고 있습니다. 이러한 개발은 민감도, 재현성, 처리 능력의 향상을 가져와 진단, 정밀의료, 연구에 필수적인 고품질 DNA/RNA를 생산할 수 있습니다.

또한, 고도의 자동화 솔루션은 현재 고처리량 PCR, NGS 라이브러리 준비, 디지털 PCR과 같은 다운스트림 기술과 긴밀하게 통합되어 수작업을 줄이고 처리 시간을 개선하고 있습니다. 전반적으로 의료 및 연구 환경이 자동화, 대량 유전체 검사, 정밀 종양학으로 전환됨에 따라 자동 핵산 추출은 현대 분자 기술에 점점 더 필수적인 요소가 되고 있습니다.

시장 연관 전망
- 상부 시장 전망
- 관련/부수 시장 전망
시장 동향과 전망
시장 성장 촉진요인
- 유전체학 및 정밀의료의 도입 확대가 핵산 추출 자동화를 추진
- 새로운 검체 유형과 과제적인 기술을 가능하게 하는 기술 혁신
시장 성장 억제요인 분석
- 운영·보수의 복잡성
비즈니스 환경 분석
- PESTEL 분석
- Porter's Five Forces 분석

제4장 제품별 사업 분석

세계의 자동 핵산 추출 시장 : 변동 분석, 제품별
기기
- 기기(2021-2033년)
시약·소모품
- 시약·소모품(2021-2033년)

제5장 기술별 사업 분석

세계의 자동 핵산 추출 시장 : 변동 분석, 기술별
자기 비즈 기반
- 자기 비즈 기반(2021-2033년)
컬럼 기반
- 컬럼 기반(2021-2033년)
기타
- 기타(2021-2033년)

제6장 용도별 사업 분석

세계의 자동 핵산 추출 시장 : 변동 분석, 용도별
DNA 추출
- DNA 추출(2021-2033년)
RNA 추출
- RNA 추출(2021-2033년)

제7장 최종 용도별 사업 분석

세계의 자동 핵산 추출 시장 : 변동 분석, 최종 용도별
대학·기타 연구기관
학술·연구기관
- 학술·조사기관(2021-2033년)
제약·바이오테크놀러지 기업
- 제약·바이오테크놀러지 기업(2021-2033년)
수탁조사기관
- CRO(의약품 임상시험수탁기관)(2021-2033년)
병원·진단 센터
- 병원·진단 센터(2021-2033년)
기타
- 기타(2021-2033년)

제8장 지역별 사업 분석

세계의 자동 핵산 추출 시장 : 시장 점유율, 지역별(2024년·2033년)
북미
- 북미의 자동 핵산 추출 시장(2021-2033년)
- 미국
- 캐나다
- 멕시코
유럽
- 유럽의 자동 핵산 추출 시장(2021-2033년)
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 아시아태평양의 자동 핵산 추출 시장(2021-2033년)
- 일본
- 중국
- 인도
- 한국
- 호주
- 태국
라틴아메리카
- 라틴아메리카의 자동 핵산 추출 시장(2021-2033년)
- 브라질
- 아르헨티나
중동 및 아프리카
- 중동 및 아프리카의 자동 핵산 추출 시장(2021-2033년)
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제9장 경쟁 구도

기업 분류
전략 매핑
기업 시장 상황 분석(2024년)
기업 개요/리스트
- Thermo Fisher Scientific, Inc.
- QIAGEN
- Merck KGaA
- F. Hoffmann-La Roche AG
- Agilent Technologies
- Revvity, Inc.
- Promega Corporation
- Bio-Rad Laboratories
- Takara Bio
- Zymo Research Corporation

KSM

영문 목차

영문목차

Automated Nucleic Acid Extraction Market Summary

The global automated nucleic acid extraction market size was valued at USD 3.22 billion in 2024 and is expected to reach USD 8.77 billion by 2033, registering a CAGR of 11.89% from 2025 to 2033. Continuous advancements in extraction technologies, combined with the growing applications of genomics in precision medicine, infectious disease testing, and biotechnology research, are further driving market expansion.

Technological innovation enabling new sample types and challenging technologies

Technological developments are stimulating the robust adoption of automated nucleic acid extraction systems by making it easier to process complex sample types, such as those with shallow volumes, clinical samples, FFPE tissues, and circulating cell-free nucleic acids. These developments will provide increased sensitivity, reproducibility, and throughput, while yielding high-quality DNA/RNA that is essential for diagnostics, precision medicine, and research.

Moreover, advanced automated solutions are now finely integrated into downstream technologies such as high-throughput PCR, NGS library preparation, and digital PCR, to lessen manual handling and improve turnaround times. Overall, as healthcare and research environments move towards automation, high-volume genomic testing, and precision oncology, automated nucleic acid extraction is increasingly essential to contemporary molecular technologies.

Global Automated Nucleic Acid Extraction Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global automated nucleic acid extraction market report on the basis of product, technology, application, end use, and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)
Instruments
Reagents & Consumables
Technology Outlook (Revenue, USD Million, 2021 - 2033)
Magnetic Bead-based
Column-based
Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
DNA Extraction
- Genomic DNA Extraction
- Plasmid DNA Extraction
- Others
RNA Extraction
- mRNA Extraction
- miRNA Extraction
- Total RNA Extraction
- Others
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Hospitals and Diagnostic Centers
Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
- 1.2.1. Information analysis
- 1.2.2. Market formulation & data visualization
- 1.2.3. Data validation & publishing
1.3. Information Procurement
- 1.3.1. Primary Others
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Market Model
1.7. Objectives
- 1.7.1. Objective 1
- 1.7.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Drivers
- 3.3.1. Rising Adoption of Genomics and Precision Medicine Driving Automation in Nucleic Acid Extraction
- 3.3.2. Technological innovation enabling new sample types and challenging technologies
3.4. Market Restraint Analysis
- 3.4.1. Operational and Maintenance Complexity
3.5. Business Environment Analysis
- 3.5.1. PESTEL Analysis
- 3.5.2. Porter's Five Forces Analysis

Chapter 4. Product Business Analysis

4.1. Global Automated Nucleic Acid Extraction Market: Service Type Movement Analysis
4.2. Instruments
- 4.2.1. Instruments, 2021 - 2033 (USD Million)
4.3. Reagents & Consumables
- 4.3.1. Reagents & Consumables, 2021 - 2033 (USD Million)

Chapter 5. Technology Business Analysis

5.1. Global Automated Nucleic Acid Extraction market: Technology Movement Analysis
5.2. Magnetic Bead-based
- 5.2.1. Magnetic Bead-based, 2021 - 2033 (USD Million)
5.3. Column-based
- 5.3.1. Column-based, 2021 - 2033 (USD Million)
5.4. Others
- 5.4.1. Others, 2021 - 2033 (USD Million)

Chapter 6. Application Business Analysis

6.1. Global Automated Nucleic Acid Extraction market: Application Movement Analysis
6.2. DNA Extraction
- 6.2.1. DNA Extraction, 2021 - 2033 (USD Million)
  - 6.2.1.1. Genomic DNA Extraction
    - 6.2.1.1.1. Genomic DNA Extraction, 2021 - 2033 (USD Million)
  - 6.2.1.2. Plasmid DNA Extraction
    - 6.2.1.2.1. Plasmid DNA Extraction, 2021 - 2033 (USD Million)
  - 6.2.1.3. Others
    - 6.2.1.3.1. Others, 2021 - 2033 (USD Million)
6.3. RNA Extraction
- 6.3.1. RNA Extraction ,2021 - 2033 (USD Million)
  - 6.3.1.1. mRNA Extraction
    - 6.3.1.1.1. mRNA Extraction, 2021 - 2033 (USD Million)
  - 6.3.1.2. miRNA Extraction
    - 6.3.1.2.1. miRNA Extraction, 2021 - 2033 (USD Million)
  - 6.3.1.3. Total RNA Extraction
    - 6.3.1.3.1. Total RNA Extraction, 2021 - 2033 (USD Million)
  - 6.3.1.4. Others
    - 6.3.1.4.1. Others, 2021 - 2033 (USD Million)

Chapter 7. End-use Business Analysis

7.1. Global Automated Nucleic Acid Extraction Market: End-use Movement Analysis
7.2. Universities & Other Research Entities
7.3. Academic & Research Institutes
- 7.3.1. Academic & Research Institutes,2021 - 2033 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
- 7.4.1. Pharmaceutical & Biotechnology Companies,2021 - 2033 (USD Million)
7.5. Contract Research Organizations
- 7.5.1. Contract Research Organizations,2021 - 2033 (USD Million)
7.6. Hospitals and Diagnostic Centers
- 7.6.1. Hospitals and Diagnostic Centers,2021 - 2033 (USD Million)
7.7. Others
- 7.7.1. Others,2021 - 2033 (USD Million)

Chapter 8. Regional Business Analysis

8.1. Global Automated Nucleic Acid Extraction Market Share by Region, 2024 & 2033
8.2. North America
- 8.2.1. North America Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.2.2. U.S.
  - 8.2.2.1. Key Country Dynamics
  - 8.2.2.2. Competitive Scenario
  - 8.2.2.3. Regulatory Framework
  - 8.2.2.4. Target Disease Prevalence
  - 8.2.2.5. U.S. Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.2.3. Canada
  - 8.2.3.1. Key Country Dynamics
  - 8.2.3.2. Competitive Scenario
  - 8.2.3.3. Regulatory Framework
  - 8.2.3.4. Target Disease Prevalence
  - 8.2.3.5. Canada Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.2.4. Mexico
  - 8.2.4.1. Key Country Dynamics
  - 8.2.4.2. Competitive Scenario
  - 8.2.4.3. Regulatory Framework
  - 8.2.4.4. Target Disease Prevalence
  - 8.2.4.5. Mexico Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
8.3. Europe
- 8.3.1. Europe Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.3.2. Germany
  - 8.3.2.1. Key Country Dynamics
  - 8.3.2.2. Competitive Scenario
  - 8.3.2.3. Regulatory Framework
  - 8.3.2.4. Target Disease Prevalence
  - 8.3.2.5. Germany Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.3.3. UK
  - 8.3.3.1. Key Country Dynamics
  - 8.3.3.2. Competitive Scenario
  - 8.3.3.3. Regulatory Framework
  - 8.3.3.4. Target Disease Prevalence
  - 8.3.3.5. UK Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.3.4. France
  - 8.3.4.1. Key Country Dynamics
  - 8.3.4.2. Competitive Scenario
  - 8.3.4.3. Regulatory Framework
  - 8.3.4.4. Target Disease Prevalence
  - 8.3.4.5. France Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.3.5. Italy
  - 8.3.5.1. Key Country Dynamics
  - 8.3.5.2. Competitive Scenario
  - 8.3.5.3. Regulatory Framework
  - 8.3.5.4. Target Disease Prevalence
  - 8.3.5.5. Italy Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.3.6. Spain
  - 8.3.6.1. Key Country Dynamics
  - 8.3.6.2. Competitive Scenario
  - 8.3.6.3. Regulatory Framework
  - 8.3.6.4. Target Disease Prevalence
  - 8.3.6.5. Spain Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.3.7. Denmark
  - 8.3.7.1. Key Country Dynamics
  - 8.3.7.2. Competitive Scenario
  - 8.3.7.3. Regulatory Framework
  - 8.3.7.4. Target Disease Prevalence
  - 8.3.7.5. Denmark Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.3.8. Sweden
  - 8.3.8.1. Key Country Dynamics
  - 8.3.8.2. Competitive Scenario
  - 8.3.8.3. Regulatory Framework
  - 8.3.8.4. Target Disease Prevalence
  - 8.3.8.5. Sweden Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.3.9. Norway
  - 8.3.9.1. Key Country Dynamics
  - 8.3.9.2. Competitive Scenario
  - 8.3.9.3. Regulatory Framework
  - 8.3.9.4. Target Disease Prevalence
  - 8.3.9.5. Norway Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
8.4. Asia Pacific
- 8.4.1. Asia Pacific Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.4.2. Japan
  - 8.4.2.1. Key Country Dynamics
  - 8.4.2.2. Competitive Scenario
  - 8.4.2.3. Regulatory Framework
  - 8.4.2.4. Target Disease Prevalence
  - 8.4.2.5. Japan Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.4.3. China
  - 8.4.3.1. Key Country Dynamics
  - 8.4.3.2. Competitive Scenario
  - 8.4.3.3. Regulatory Framework
  - 8.4.3.4. Target Disease Prevalence
  - 8.4.3.5. China Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.4.4. India
  - 8.4.4.1. Key Country Dynamics
  - 8.4.4.2. Competitive Scenario
  - 8.4.4.3. Regulatory Framework
  - 8.4.4.4. Target Disease Prevalence
  - 8.4.4.5. India Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.4.5. South Korea
  - 8.4.5.1. Key Country Dynamics
  - 8.4.5.2. Competitive Scenario
  - 8.4.5.3. Regulatory Framework
  - 8.4.5.4. Target Disease Prevalence
  - 8.4.5.5. South Korea Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.4.6. Australia
  - 8.4.6.1. Key Country Dynamics
  - 8.4.6.2. Competitive Scenario
  - 8.4.6.3. Regulatory Framework
  - 8.4.6.4. Target Disease Prevalence
  - 8.4.6.5. Australia Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.4.7. Thailand
  - 8.4.7.1. Key Country Dynamics
  - 8.4.7.2. Competitive Scenario
  - 8.4.7.3. Regulatory Framework
  - 8.4.7.4. Target Disease Prevalence
  - 8.4.7.5. Thailand Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
8.5. Latin America
- 8.5.1. Latin America Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.5.2. Brazil
  - 8.5.2.1. Key Country Dynamics
  - 8.5.2.2. Competitive Scenario
  - 8.5.2.3. Regulatory Framework
  - 8.5.2.4. Target Disease Prevalence
  - 8.5.2.5. Brazil Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.5.3. Argentina
  - 8.5.3.1. Key Country Dynamics
  - 8.5.3.2. Competitive Scenario
  - 8.5.3.3. Regulatory Framework
  - 8.5.3.4. Target Disease Prevalence
  - 8.5.3.5. Argentina Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
8.6. MEA
- 8.6.1. MEA Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.6.2. South Africa
  - 8.6.2.1. Key Country Dynamics
  - 8.6.2.2. Competitive Scenario
  - 8.6.2.3. Regulatory Framework
  - 8.6.2.4. Target Disease Prevalence
  - 8.6.2.5. South Africa Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.6.3. Saudi Arabia
  - 8.6.3.1. Key Country Dynamics
  - 8.6.3.2. Competitive Scenario
  - 8.6.3.3. Regulatory Framework
  - 8.6.3.4. Target Disease Prevalence
  - 8.6.3.5. Saudi Arabia Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.6.4. UAE
  - 8.6.4.1. Key Country Dynamics
  - 8.6.4.2. Competitive Scenario
  - 8.6.4.3. Regulatory Framework
  - 8.6.4.4. Target Disease Prevalence
  - 8.6.4.5. UAE Automated nucleic acid extraction market, 2021 - 2033 (USD Million)
- 8.6.5. Kuwait
  - 8.6.5.1. Key Country Dynamics
  - 8.6.5.2. Competitive Scenario
  - 8.6.5.3. Regulatory Framework
  - 8.6.5.4. Target Disease Prevalence
  - 8.6.5.5. Kuwait Automated nucleic acid extraction market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
- 9.4.1. Thermo Fisher Scientific, Inc.
  - 9.4.1.1. Overview
  - 9.4.1.2. Financial Performance
  - 9.4.1.3. Product Benchmarking
  - 9.4.1.4. Strategic Initiatives
- 9.4.2. QIAGEN
  - 9.4.2.1. Overview
  - 9.4.2.2. Financial Performance
  - 9.4.2.3. Product Benchmarking
  - 9.4.2.4. Strategic Initiatives
- 9.4.3. Merck KGaA
  - 9.4.3.1. Overview
  - 9.4.3.2. Financial Performance
  - 9.4.3.3. Product Benchmarking
  - 9.4.3.4. Strategic Initiatives
- 9.4.4. F. Hoffmann-La Roche AG
  - 9.4.4.1. Overview
  - 9.4.4.2. Financial Performance
  - 9.4.4.3. Product Benchmarking
  - 9.4.4.4. Strategic Initiatives
- 9.4.5. Agilent Technologies
  - 9.4.5.1. Overview
  - 9.4.5.2. Financial Performance
  - 9.4.5.3. Product Benchmarking
  - 9.4.5.4. Strategic Initiatives
- 9.4.6. Revvity, Inc.
  - 9.4.6.1. Overview
  - 9.4.6.2. Financial Performance
  - 9.4.6.3. Product Benchmarking
  - 9.4.6.4. Strategic Initiatives
- 9.4.7. Promega Corporation
  - 9.4.7.1. Overview
  - 9.4.7.2. Financial Performance
  - 9.4.7.3. Product Benchmarking
  - 9.4.7.4. Strategic Initiatives
- 9.4.8. Bio-Rad Laboratories
  - 9.4.8.1. Overview
  - 9.4.8.2. Financial Performance
  - 9.4.8.3. Product Benchmarking
  - 9.4.8.4. Strategic Initiatives
- 9.4.9. Takara Bio
  - 9.4.9.1. Overview
  - 9.4.9.2. Financial Performance
  - 9.4.9.3. Product Benchmarking
  - 9.4.9.4. Strategic Initiatives
- 9.4.10. Zymo Research Corporation
  - 9.4.10.1. Overview
  - 9.4.10.2. Financial Performance
  - 9.4.10.3. Product Benchmarking
  - 9.4.10.4. Strategic Initiatives